In breast care, seeing the difference can make the difference in a woman’s life. Reveal all that matters with MAMMOMAT Revelation. Achieve the highest depth resolution with the unique 50° HD Breast Tomosynthesis. Leverage precision patient care with Insight BD direct breast density measurement, which allows instant risk stratification – before the patient leaves. And with our Personalized Soft Compression you can address your patient's concerns about discomfort in a unique way.
MAMMOMAT RevelationSee the difference. Make the difference.
1
Option
2
Maldera et al. (2016): Digital breast tomosynthesis: Dose and image quality assessment. Physica Medica, pp. 1-12.; Marshall N.W. and Bosmans H. (2012): Measurements of system sharpness for two digital breast tomosynthesis systems. Phys. Med. Biol. 57, pp. 7629-7650.; Rodríguez-Ruiz A. et al. (2016): Evaluation of the technical performance of three different commercial digital breast tomosynthesis systems in the clinical environment. Physica Medica 32, pp. 767-777.
3
Maldera et al. (2016): Digital breast tomosynthesis: Dose and image quality assessment. Physica Medica, pp. 1-12.; Marshall N.W. and Bosmans H. (2012): Measurements of system sharpness for two digital breast tomosynthesis systems. Phys. Med. Biol. 57, pp. 7629-7650.; Rodríguez-Ruiz A. et al. (2016): Evaluation of the technical performance of three different commercial digital breast tomosynthesis systems in the clinical environment. Physica Medica 32, pp. 767-777.
4
Uchiyama N. et al. (2016): Diagnostic Usefulness of Synthetic MMG (SMMG) with DBT (Digital Breast tomosynthesis) for Clinical – Setting in Breast Cancer Screening. Springer International Publishing Switzerland. IWDM 2016, LNCS 9699, pp. 59–67.
5
Lång K. et al. (2016): Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmö BreastTomosynthesis Screening Trial, a population-based study. Eur Radiol 26, pp. 184-190. (Please note: Final result will be presented at RSNA 2017)
6
“1-view tomo only” is not FDA approved in the U.S.
7
Compared to grid-based acquisition with Mammomat Inspiration, depending on breast thickness - L.B. Larsen, A. Fieselmann, H. Pfaff, T. Mertelmeier Performance of grid-less digital mammography acquisition technique for breast screening: analysis of 22,117 examinations Presentation B-1025 ECR 2015
The statements by Siemens Healthineers’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.
MAMMOMAT Revelation is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.